Literature DB >> 18447613

Preventing HIV antiretroviral resistance through better monitoring of treatment adherence.

David R Bangsberg1.   

Abstract

Suboptimal adherence to antiretroviral therapy (ART) is the most common cause of viral rebound. Accurate and reliable measures of ART adherence will be needed in the transition from reactive response to proactive prevention of viral rebound in the era of chronic human immunodeficiency virus (HIV) disease management. Such tools could define individual "signature adherence patterns," which could inform regimen choice and guide behavioral intervention. Upcoming advances in adherence monitoring present opportunities to better match HIV-disease treatment strategies with individual adherence behavior.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18447613     DOI： 10.1086/533415

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


  79 in total

1.  Non-adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies.

Authors:  John M Kane; Taishiro Kishimoto; Christoph U Correll
Journal:  World Psychiatry       Date:  2013-10       Impact factor: 49.548

Review 2.  A Review of HIV-Specific Patient-Reported Outcome Measures.

Authors:  Kim Engler; David Lessard; Bertrand Lebouché
Journal:  Patient       Date:  2017-04       Impact factor: 3.883

Review 3.  Antiretroviral therapy in macrophages: implication for HIV eradication.

Authors:  Christina Gavegnano; Raymond F Schinazi
Journal:  Antivir Chem Chemother       Date:  2009-10-19

4.  Pill Burden Influences the Association Between Time-Based Prospective Memory and Antiretroviral Therapy Adherence in Younger But Not Older HIV-Infected Adults.

Authors:  David P Sheppard; Erica Weber; Kaitlin B Casaletto; Gunes Avci; Steven Paul Woods
Journal:  J Assoc Nurses AIDS Care       Date:  2016-04-06       Impact factor: 1.354

5.  Pharmacy adherence measures to assess adherence to antiretroviral therapy: review of the literature and implications for treatment monitoring.

Authors:  James H McMahon; Michael R Jordan; Karen Kelley; Silvia Bertagnolio; Steven Y Hong; Christine A Wanke; Sharon R Lewin; Julian H Elliott
Journal:  Clin Infect Dis       Date:  2011-01-18       Impact factor: 9.079

6.  Validating five questions of antiretroviral nonadherence in a public-sector treatment program in rural South Africa.

Authors:  Krisda Chaiyachati; Lisa R Hirschhorn; Frank Tanser; Marie-Louise Newell; Till Bärnighausen
Journal:  AIDS Patient Care STDS       Date:  2011-01-26       Impact factor: 5.078

7.  Pharmacy and self-report adherence measures to predict virological outcomes for patients on free antiretroviral therapy in Tamil Nadu, India.

Authors:  James H McMahon; Anand Manoharan; Christine A Wanke; Shoba Mammen; Hepsibah Jose; Thabeetha Malini; Tony Kadavanu; Michael R Jordan; Julian H Elliott; Sharon R Lewin; Dilip Mathai
Journal:  AIDS Behav       Date:  2013-07

8.  Efficacy of raltegravir, etravirine and darunavir/ritonavir for treatment-experienced HIV patients from a non-urban clinic population in the United States.

Authors:  Andrew M Ebers; Yusra Alkabab; Brian Wispelwey; Rebecca Dillingham; Xin-Qun Wang; Julie Schexnayder; Scott K Heysell
Journal:  Ther Adv Infect Dis       Date:  2017-07-13

9.  Prospective memory and antiretroviral medication non-adherence in HIV: an analysis of ongoing task delay length using the memory for intentions screening test.

Authors:  Amelia J Poquette; David J Moore; Ben Gouaux; Erin E Morgan; Igor Grant; Steven Paul Woods
Journal:  J Int Neuropsychol Soc       Date:  2012-10-25       Impact factor: 2.892

10.  Pilot testing of an HIV medication adherence intervention in a public clinic in the Deep South.

Authors:  Deborah J Konkle-Parker; Judith A Erlen; Patricia M Dubbert; Warran May
Journal:  J Am Acad Nurse Pract       Date:  2012-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.